These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11451043)

  • 1. Population pharmacokinetic-pharmacodynamic model of craving in an enforced smoking cessation population: indirect response and probabilistic modeling.
    Gomeni R; Teneggi V; Iavarone L; Squassante L; Bye A
    Pharm Res; 2001 Apr; 18(4):537-43. PubMed ID: 11451043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation and predictive performances of saliva and plasma nicotine concentration on tobacco withdrawal-induced craving.
    Teneggi V; Squassante L; Iavarone L; Milleri S; Bye A; Gomeni R
    Br J Clin Pharmacol; 2002 Oct; 54(4):407-14. PubMed ID: 12392589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
    Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
    Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic modeling of the effect of varenicline on nicotine craving in adult smokers.
    Ravva P; Gastonguay MR; Faessel HM; Lee TC; Niaura R
    Nicotine Tob Res; 2015 Jan; 17(1):106-13. PubMed ID: 25145377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of varenicline on stress-induced and cue-induced craving for cigarettes.
    Ray LA; Lunny K; Bujarski S; Moallem N; Krull JL; Miotto K
    Drug Alcohol Depend; 2013 Jul; 131(1-2):136-42. PubMed ID: 23298651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of beliefs regarding drug assignment in experimental and field studies of nicotine delivery devices: a review.
    Dar R; Barrett SP
    J Psychopharmacol; 2014 Nov; 28(11):1071-9. PubMed ID: 25253274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation.
    Wallström M; Nilsson F; Hirsch JM
    Addiction; 2000 Aug; 95(8):1161-71. PubMed ID: 11092064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
    Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
    Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ability of a new oral nicotine substitute to reduce smoking urge in moderate smokers.
    Demazières A; Luthringer R; Coppel E; Gilles C; Fleury C; Roegel JC; Delarue A; Laur C; Lagrue G
    Addict Behav; 2006 Mar; 31(3):537-43. PubMed ID: 15964703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in craving for a cigarette and arterial nicotine plasma concentrations in abstinent smokers.
    Guthrie SK; Ni L; Zubieta JK; Teter CJ; Domino EF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):617-23. PubMed ID: 15276686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study.
    Batra A; Klingler K; Landfeldt B; Friederich HM; Westin A; Danielsson T
    Clin Pharmacol Ther; 2005 Dec; 78(6):689-96. PubMed ID: 16338284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of social anxiety on urge and craving among smokers with and without anxiety disorders.
    Kimbrel NA; Morissette SB; Gulliver SB; Langdon KJ; Zvolensky MJ
    Drug Alcohol Depend; 2014 Feb; 135():59-64. PubMed ID: 24331637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving.
    Selby P; Andriash K; Zawertailo L; Persad D; Zack M; Busto UE
    J Clin Psychopharmacol; 2013 Oct; 33(5):667-74. PubMed ID: 23963055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine patches in smoking cessation: a randomized trial among over-the-counter customers in Denmark.
    Sønderskov J; Olsen J; Sabroe S; Meillier L; Overvad K
    Am J Epidemiol; 1997 Feb; 145(4):309-18. PubMed ID: 9054234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-control depletion and nicotine deprivation as precipitants of smoking cessation failure: A human laboratory model.
    Heckman BW; MacQueen DA; Marquinez NS; MacKillop J; Bickel WK; Brandon TH
    J Consult Clin Psychol; 2017 Apr; 85(4):381-396. PubMed ID: 28333537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of smoking urges with intranasal insulin: a randomized, crossover, placebo-controlled clinical trial.
    Hamidovic A; Khafaja M; Brandon V; Anderson J; Ray G; Allan AM; Burge MR
    Mol Psychiatry; 2017 Oct; 22(10):1413-1421. PubMed ID: 28242873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family support and employment as predictors of smoking cessation success: a randomized, double-blind, placebo-controlled trial of nicotine sublingual tablets in chinese smokers.
    Sun HQ; Guo S; Chen DF; Jiang ZN; Liu Y; Di XL; Yang FD; Zhang XY; Kosten TR; Lu L
    Am J Drug Alcohol Abuse; 2009; 35(3):183-8. PubMed ID: 19462302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airway sensory replacement combined with nicotine replacement for smoking cessation. A randomized, placebo-controlled trial using a citric acid inhaler.
    Westman EC; Behm FM; Rose JE
    Chest; 1995 May; 107(5):1358-64. PubMed ID: 7750331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day.
    Daughton DM; Fortmann SP; Glover ED; Hatsukami DK; Heatley SA; Lichtenstein E; Repsher L; Millatmal T; Killen JD; Nowak RT; Ullrich F; Patil KD; Rennard SI
    Prev Med; 1999 Feb; 28(2):113-8. PubMed ID: 10048102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.